Search

Philip A Khairallah

from Scottsdale, AZ
Deceased

Philip Khairallah Phones & Addresses

  • 6633 Greenway Rd, Scottsdale, AZ 85254 (480) 699-2241
  • 6633 Greenway Pkwy, Scottsdale, AZ 85254 (480) 699-2241
  • Chagrin Falls, OH
  • Boca Raton, FL
  • 16180 Lucky Bell Ln, Newbury, OH 44065 (440) 564-9690
  • Cleveland, OH
  • Seattle, WA

Resumes

Resumes

Philip Khairallah Photo 1

Senior Scientist

View page
Location:
Phoenix, AZ
Industry:
Research
Work:
Sun Health Research Institute
Senior Scientist
Education:
Columbia University In the City of New York 1951 - 1951
Doctor of Medicine, Doctorates, Medicine
Skills:
Cell Culture
Clinical Research
Research
Life Sciences
Clinical Trials
Molecular Biology
Cell Biology
Teaching
Biochemistry
Public Speaking
Data Analysis
Philip Khairallah Photo 2

Senior Scientist At Sun Health Researh Institute

View page
Location:
Phoenix, Arizona Area
Industry:
Hospital & Health Care
Experience:
Sun Health Researh Institute (Hospital & Health Care industry): Senior Scientist,  (-) 

Publications

Us Patents

Afinity Biosensor For Monitoring Biological Process

View page
US Patent:
20040186359, Sep 23, 2004
Filed:
Jan 9, 2004
Appl. No.:
10/483586
Inventors:
Stephen Beaudoin - West Lafayette IN, US
Karl Booksh - Gilbert AL, US
Philip Khairallah - Scottsdale AZ, US
Hassan Loutfi - Scottsdale AZ, US
Alyssa Panitch - Highley AZ, US
International Classification:
A61B006/00
US Classification:
600/310000, 600/476000, 356/039000
Abstract:
An optical biosensor carries one or more affinity legends or binding members that bind specifically to a marker being monitored. Light directed along optic fibers illuminates a surface plasmon resonance (SPRN) probe surface on which is immobilized the binding member. A spectrophotometer receives light reflected back along the fiber optic path and provides wavelength information indicative of the absence or presence of surface plasmon resonance indicative of the bound marker in known SPR manner. The probe is used in vitro or in vivo. When used in vivo the fiberoptic light path comprises a catheter that directs the probe to an implant site. For in vivo implantation a housing houses the probe at the implant site and is adapted to filter out larger particles that would adversely affect with the spectral analysis. In one embodiment the probe has two regions on its surface. The first region has no immobilized binding member. The second region does have the binding member immobilized on it. Light returned from the first and second regions can be compared. The presence or absence of a marker bound by the binding member on the second surface is apparent in the similarity or dissimilarity of the spectral information returned from the two regions. The probe can monitor blood, spinal fluid, mucus membrane, wound tissue, implanted organs, urine and other substances for the presence of a marker which may be indicative of a medical condition in an animal or human subject.
Philip A Khairallah from Scottsdale, AZDeceased Get Report